The 1 analysts offering 12-month price forecasts for BiondVax Pharmaceuticals Ltd have a median target of 70.00, with a high estimate of 70.00 and a low estimate of 70.00. The median estimate represents a +692.75% increase from the last price of 8.83.
The current consensus among 1 polled investment analysts is to Buy stock in BiondVax Pharmaceuticals Ltd. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.10
Reporting Date Nov 29
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.